INS and Hypoglycemia: Additionally, β2-receptor blockade in the liver and skeletal muscle may reduce glycogenolysis and insulin-mediated glucose uptake, increasing the risk of hypoglycemia or impaired exercise tolerance, especially in diabetic or insulin-resistant patients [81,82].